日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring the protective effect and molecular mechanism of betulin in Alzheimer's disease based on network pharmacology, molecular docking and experimental validation

基于网络药理学、分子对接及实验验证探索白桦脂醇对阿尔茨海默病的保护作用及分子机制

Na Wang #, Jiali Cui #, Ziteng Sun, Fan Chen, Xiaping He

The Protective Effect of Mangiferin on Formaldehyde-Induced HT22 Cell Damage and Cognitive Impairment

芒果苷对甲醛诱导的HT22细胞损伤及认知障碍的保护作用

Fan Chen, Na Wang, Xinyan Tian, Juan Su, Yan Qin, Rongqiao He, Xiaping He

Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study

基底样乳腺癌原位至侵袭性进展的分子特征:综合小鼠模型和人类 DCIS 研究

Aatish Thennavan, Susana Garcia-Recio, Siyao Liu, Xiaping He, Charles M Perou

Entinostat induces antitumor immune responses through immune editing of tumor neoantigens

恩替诺特通过对肿瘤新抗原的免疫编辑诱导抗肿瘤免疫反应

Andrew S Truong ,Mi Zhou ,Bhavani Krishnan ,Takanobu Utsumi ,Ujjawal Manocha ,Kyle G Stewart ,Wolfgang Beck ,Tracy L Rose ,Matthew I Milowsky ,Xiaping He ,Christof C Smith ,Lisa M Bixby ,Charles M Perou ,Sara E Wobker ,Sean T Bailey ,Benjamin G Vincent ,William Y Kim

FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036

TBCRC 036 中 FOXA1 和 HER2 靶向治疗的适应性反应决定因素

Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, Samantha M Bevill, Daniel R Goulet, J Felix Olivares-Quintero, Michael P East, Maki Tanioka, Jon S Zawistowski, Darshan Singh, Noah Sciaky, Xin Chen, Xiaping He, Naim U Rashid, Lynn Chollet-Hinton, Cheng Fan, Matthew G Soloway, Patricia A Spears, 

Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics

肿瘤抑制因子 PLK2 可作为三阴性乳腺癌的生物标志物,以改善对 PLK1 疗法的反应

Yang Gao, Elena B Kabotyanski, Jonathan H Shepherd, Elizabeth Villegas, Deanna Acosta, Clark Hamor, Tingting Sun, Celina Montmeyor-Garcia, Xiaping He, Lacey E Dobrolecki, Thomas F Westbrook, Michael T Lewis, Susan G Hilsenbeck, Xiang H-F Zhang, Charles M Perou, Jeffrey M Rosen

FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

FGFR4调控管腔型乳腺癌和转移性疾病中的肿瘤亚型分化

Susana Garcia-Recio,Aatish Thennavan,Michael P East,Joel S Parker,Juan M Cejalvo,Joseph P Garay,Daniel P Hollern,Xiaping He,Kevin R Mott,Patricia Galván,Cheng Fan,Sara R Selitsky,Alisha R Coffey,David Marron,Fara Brasó-Maristany,Octavio Burgués,Joan Albanell      0   ,Federico Rojo    ,Ana Lluch      ,Eduardo Martinez de Dueñas    ,Jeffery M Rosen,Gary L Johnson,Lisa A Carey,Aleix Prat    ,Charles M Perou      0

Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer

通过联合疫苗和 αPD-1 刺激致癌基因特异性肿瘤浸润 T 细胞,实现对已确诊的 HER2 乳腺癌的持续抗肿瘤反应

Erika J Crosby, Chaitanya R Acharya, Anthony-Fayez Haddad, Christopher A Rabiola, Gangjun Lei, Jun-Ping Wei, Xiao-Yi Yang, Tao Wang, Cong-Xiao Liu, Kay U Wagner, William J Muller, Lewis A Chodosh, Gloria Broadwater, Terry Hyslop, Jonathan H Shepherd, Daniel P Hollern, Xiaping He, Charles M Perou, Sh

B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer

B细胞和滤泡辅助性T细胞介导高突变负荷乳腺癌小鼠模型对检查点抑制剂的反应

Daniel P Hollern,Nuo Xu,Aatish Thennavan,Cherise Glodowski,Susana Garcia-Recio,Kevin R Mott,Xiaping He,Joseph P Garay,Kelly Carey-Ewend,David Marron,John Ford,Siyao Liu,Sarah C Vick,Miguel Martin,Joel S Parker,Benjamin G Vincent,Jonathan S Serody,Charles M Perou

Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast

Cdh1 和 Pik3ca 突变协同诱发乳腺免疫相关性浸润性小叶癌

Yeji An ,Jessica R Adams ,Daniel P Hollern ,Anthony Zhao ,Stephen G Chang ,Miki S Gams ,Philip E D Chung ,Xiaping He ,Rhea Jangra ,Juhi S Shah ,Joanna Yang ,Lauren A Beck ,Nandini Raghuram ,Katelyn J Kozma ,Amanda J Loch ,Wei Wang ,Cheng Fan ,Susan J Done ,Eldad Zacksenhaus ,Cynthia J Guidos ,Charles M Perou ,Sean E Egan